Cleared Traditional

K102534 - AZE VIRTUALPLACE-MR FLOW ANALYSIS SOFTWARE

K102534 is an FDA 510(k) clearance for AZE VIRTUALPLACE-MR FLOW ANALYSIS SOFTWARE, manufactured by Aze, Ltd.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 263-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
May 2011
Decision
263d
Days
Class 2
Risk

K102534 is an FDA 510(k) clearance for the AZE VIRTUALPLACE-MR FLOW ANALYSIS SOFTWARE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Aze, Ltd. (Minneapolis, US). The FDA issued a Cleared decision on May 24, 2011 after a review of 263 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K102534

510(k) Number K102534 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 03, 2010
Decision Date May 24, 2011
Days to Decision 263 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
156d slower than avg
Panel avg: 107d · This submission: 263d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2241
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K102534.
MD301C4 29.8 DIAGNOSTIC IMAGING LCD MONITOR, L309TY
K111237 · Nec Display Solutions , Ltd. · Jun 2011
10 MP GRAYSCALE FLAT PANEL DISPLAY (GX 1030)
K103724 · Eizo GmbH · Jun 2011
ECHOINSIGHT
K110447 · Ultrasound Medical Devices, Inc. · May 2011
EBW NM 2.0
K111336 · Philips Medical Systems (Cleveland), Inc. · May 2011
SICAT IMPLANT V1.2
K103723 · Sicat GmbH & Co. KG · May 2011
SYNGO NEURO PBV-IR
K111052 · Siemens Medical Solutions USA, Inc. · May 2011